Please assess the completion status of the following clinical trial:

Trial Title: Morphine IV vs Paracetamol IV in Neonates and Infants After Cardiac Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Informed consent~* Neonates/infants who are 0-36 months old~* Cardiac surgery with the use of CPB.~Exclusion Criteria:~* No informed consent~* Known allergy to or intolerance of paracetamol or morphine~* Administration of opioids in the 24 h prior to surgery~* Hepatic dysfunction defined as three times the reference value of alanine aminotransferase/aspartate aminotransferase (ALAT/ASAT)~* Renal insufficiency at least RIFLE category Risk prior to surgery.

- Gender: ALL
- Minimum Age: 1 Day
- Maximum Age: 36 Months
- Healthy Volunteers: f

Study Arms:
- morphine (Type: OTHER): Standard care, continuous morphine IV.
- paracetamol (Type: ACTIVE_COMPARATOR): intervention group, intermittent paracetamol IV

Based on this trial design, predict the completion outcome and termination type (if applicable).